ORLANDO, Fla. (Ivanhoe Newswire) - Pancreatic cancer is a stubborn and difficult cancer to treat. In fact, it has the highest death rate of all major cancers. Now, researchers have found a new ...

Pancreatic cancer is one of the most difficult cancers to treat — and the deadliest. Fewer than 10% of patients with advanced pancreatic cancer live beyond five years. A few factors account for this.

Researchers have demonstrated in mice a new method to combat pancreatic cancer. The study outlines the synergistic effects of a novel nanoparticle drug-delivery system to activate an immune pathway in ...

Scientists at Memorial Sloan Kettering Cancer Center have developed personalized mRNA vaccines for pancreatic cancer, with ...

Pancreatic cancer is a very challenging disease. It’s tough to catch early, spreads rapidly, and doesn’t respond easily to treatment. This year, pancreatic cancer is expected to be the 12th most ...

BUFFALO, N.Y. — Pancreatic cancer is one of the most difficult cancers to treat — and the deadliest. Fewer than 10% of patients with advanced pancreatic cancer live beyond five years. A few factors ...

Long before mRNA vaccines captured global attention during the COVID-19 pandemic, researchers were already exploring their potential to revolutionize medicine. At Memorial Sloan Kettering Cancer ...

Scientists at UCLA have developed an “off-the-shelf” cell-based immunotherapy that was able to track down and kill pancreatic cancer cells even after they had spread to other organs. In a mouse study, ...

A new blood test that uses artificial intelligence (AI) may offer a faster, more accurate way to determine whether pancreatic cancer treatment is working. Known as ARTEMIS-DELFI, the test detects DNA ...

Researchers at the University of Massachusetts Amherst and UMass Chan Medical School have demonstrated in mice a new method to combat pancreatic cancer. The study, published in Science Translational ...